SavedAdd your journal

Journals / Glokom Katarakt / 2020 / Cilt: 29 - Sayı: 2

Tube Migration Associated with Hypotony After Xen Implantation and Its Management

Zeynep AKTAS
Gokcen Deniz GULPINAR
Murat HASANREISOGLU
Pages
130–132
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

XEN implant is a microinvasive surgical treatment of glaucoma, and tube migration with hypotony might be encountered as an early postoperative complication.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:We report a case of primary open angle glaucoma uncontrolled with maximum medical therapy in left eye, which underwent XEN implant surgery.
📊
Key Findings & Data:Intraocular pressure (IOP) was measured as 11 mmHg and 3mmHg on the fi rst and third postoperative days, respectively.
💡
Conclusion & Impact:XEN implant is a microinvasive surgical treatment of glaucoma, and tube migration with hypotony might be encountered as an early postoperative complication.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

We report a case of primary open angle glaucoma uncontrolled with maximum medical therapy in left eye, which underwent XEN implant surgery. Intraocular pressure (IOP) was measured as 11 mmHg and 3mmHg on the fi rst and third postoperative days, respectively. Examination of the operated eye on the third post operative day revealed decrease in visual acuity, hypotony maculopathy and migration of the collagen implant towards the anterior chamber. After the injection of viscoelastic into the anterior chamber, IOP had risen to 19 mmHg. XEN implant is a microinvasive surgical treatment of glaucoma, and tube migration with hypotony might be encountered as an early postoperative complication.

🔖

Cite This Article

AKTAS, Z., GULPINAR, G. D., HASANREISOGLU, M. (2020). Tube Migration Associated with Hypotony After Xen Implantation and Its Management. Glokom Katarakt, Cilt: 29 - Sayı: 2, 130–132. https://ajindex.com/articles/226404

References (10)

  1. Heijl A, Leske C, Bengtsson B, et al. Reduction of intraocular pressure and glaucoma progression. Arch Ophthalmol 2002; 120: 1268-79
  2. Tham YC, Li X, Wong TY, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121:2081–90
  3. Freedman J. What is new after 40 years of glaucoma implants. J Glaucoma. 2010;19:504–8
  4. Nathan MK, Jing W, Keith B. Minimally invasive glaucoma surgery as primary stand-alone surgery for glaucoma. Clinical and Experimental Ophthalmology 2016;45:393-400
  5. Sheybani A, Reitsamer H, Ahmed II. Fluid Dynamics of a novel micro-fi stula implant for the surgical treatment of glaucoma. Invest Ophthalmol Vis Sci, 2015;56:4789–95
  6. Vera V, Ahmed IIK, Stalmans I et al. Gel Stent ImplantationRecommendations for Preoperative Assessment, SurgicalTechnique, and Postoperative Management. US Ophtalmic Review. 2018;11:38–46
  7. Ali ZC, Khoo DI, Stringa F et al. Migration of XEN45 Implant: Findings, Mechanism, and Management. J Curr Glaucoma Pract. 2019;13:79-81
  8. Karimi A, Lindfi eld D, Turnbull A, et al. A multicentre interventional case series of 259 abinterno Xen gel implants for glaucoma, with and without combined cataract surgery.Eye (Lond). 2019;33:469-77
  9. Atalay K, Nacaroglu SA, Kirgiz A. Complication of microbypass stenting: the anterior chamber displacement of a Xen implant.Arq Bras Oftalmol. 2018;81:514-6 10- Dervenis N, Mikropoulou AM, Dervenis P, et al. Dislocation of a previously successful XEN glaucoma implant into the anterior chamber: a case report. BMC Ophthalmol. 2017:22;17:148
  10. Gillmann K, Bravetti EG, Mermoud A, et al. Anterior Chamber XEN Gel Stent Movements: The Impact on Corneal Endothelial Cell Density. J Glaucoma. 2019 Jun;28:e93-e95.